Relmada Therapeutics, Inc. · NASDAQ:RLMD
BlackRock, Inc. reported a 7.00% stake in Relmada Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 7.00% stake in Relmada Therapeutics, Inc., 7,352,913 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 7.00%
- Shares
- 7,352,913
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.00% | 7,352,913 |
Source
Related
- Relmada Therapeutics, Inc.
- BlackRock, Inc.
- Relmada Therapeutics, Inc. shareholders
- Form 4 · Shenouda Maged · Sep 11, 2026
- Form 4 · Traversa Sergio · Sep 11, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G · Millennium Management LLC · Jun 22, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Jun 9, 2026